Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
Cancer therapies have revolutionized patient survival rates, yet they come with the risk of cardiotoxicity, necessitating effective monitoring and management. The existing guidelines offer a limited empirical basis for practical approaches in various clinical scenarios. This article explores the int...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/13/10/2103 |
_version_ | 1797573259074469888 |
---|---|
author | Carla Contaldi Vincenzo Montesarchio Dario Catapano Luigi Falco Francesca Caputo Carmine D’Aniello Daniele Masarone Giuseppe Pacileo |
author_facet | Carla Contaldi Vincenzo Montesarchio Dario Catapano Luigi Falco Francesca Caputo Carmine D’Aniello Daniele Masarone Giuseppe Pacileo |
author_sort | Carla Contaldi |
collection | DOAJ |
description | Cancer therapies have revolutionized patient survival rates, yet they come with the risk of cardiotoxicity, necessitating effective monitoring and management. The existing guidelines offer a limited empirical basis for practical approaches in various clinical scenarios. This article explores the intricate relationship between cancer therapy and the cardiovascular system, highlighting the role of advanced multimodality imaging in monitoring patients before, during, and after cancer treatment. This review outlines the cardiovascular effects of different cancer therapy classes, offering a comprehensive understanding of their dose- and time-dependent impacts. This paper delves into diverse imaging modalities such as echocardiography, cardiac magnetic resonance imaging, cardiac computed tomography, and nuclear imaging, detailing their strengths and limitations in various conditions due to cancer treatment, such as cardiac dysfunction, myocarditis, coronary artery disease, Takotsubo cardiomyopathy, pulmonary hypertension, arterial hypertension, valvular heart diseases, and heart failure with preserved ejection fraction. Moreover, it underscores the significance of long-term follow-up for cancer survivors and discusses future directions. |
first_indexed | 2024-03-10T21:07:18Z |
format | Article |
id | doaj.art-d20358a99f584a748e4644ebeb3c09c8 |
institution | Directory Open Access Journal |
issn | 2075-1729 |
language | English |
last_indexed | 2024-03-10T21:07:18Z |
publishDate | 2023-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Life |
spelling | doaj.art-d20358a99f584a748e4644ebeb3c09c82023-11-19T17:07:27ZengMDPI AGLife2075-17292023-10-011310210310.3390/life13102103Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer TherapyCarla Contaldi0Vincenzo Montesarchio1Dario Catapano2Luigi Falco3Francesca Caputo4Carmine D’Aniello5Daniele Masarone6Giuseppe Pacileo7Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyDivision of Medical Oncology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyHeart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyHeart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyDivision of Medical Oncology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyDivision of Medical Oncology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyHeart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyHeart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyCancer therapies have revolutionized patient survival rates, yet they come with the risk of cardiotoxicity, necessitating effective monitoring and management. The existing guidelines offer a limited empirical basis for practical approaches in various clinical scenarios. This article explores the intricate relationship between cancer therapy and the cardiovascular system, highlighting the role of advanced multimodality imaging in monitoring patients before, during, and after cancer treatment. This review outlines the cardiovascular effects of different cancer therapy classes, offering a comprehensive understanding of their dose- and time-dependent impacts. This paper delves into diverse imaging modalities such as echocardiography, cardiac magnetic resonance imaging, cardiac computed tomography, and nuclear imaging, detailing their strengths and limitations in various conditions due to cancer treatment, such as cardiac dysfunction, myocarditis, coronary artery disease, Takotsubo cardiomyopathy, pulmonary hypertension, arterial hypertension, valvular heart diseases, and heart failure with preserved ejection fraction. Moreover, it underscores the significance of long-term follow-up for cancer survivors and discusses future directions.https://www.mdpi.com/2075-1729/13/10/2103cardiotoxicityechocardiographycardiac magnetic resonancecardiac computed tomographynuclear imagingcancer therapy |
spellingShingle | Carla Contaldi Vincenzo Montesarchio Dario Catapano Luigi Falco Francesca Caputo Carmine D’Aniello Daniele Masarone Giuseppe Pacileo Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy Life cardiotoxicity echocardiography cardiac magnetic resonance cardiac computed tomography nuclear imaging cancer therapy |
title | Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy |
title_full | Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy |
title_fullStr | Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy |
title_full_unstemmed | Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy |
title_short | Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy |
title_sort | multimodality cardiovascular imaging of cardiotoxicity due to cancer therapy |
topic | cardiotoxicity echocardiography cardiac magnetic resonance cardiac computed tomography nuclear imaging cancer therapy |
url | https://www.mdpi.com/2075-1729/13/10/2103 |
work_keys_str_mv | AT carlacontaldi multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy AT vincenzomontesarchio multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy AT dariocatapano multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy AT luigifalco multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy AT francescacaputo multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy AT carminedaniello multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy AT danielemasarone multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy AT giuseppepacileo multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy |